Calculator
Half chrysamine G
A "half-molecule" of Chrysamine G, the well-known marker for beta-amyloid deposition, offers protection against beta-amyloid 25-35 and beta-amyloid 40-induced neuronal death at a concentration of 0.1-1 ?M. It is shown to cross the blood brain barrier. This molecule possesses minimal in vivo toxicity and displays low affinity to beta-amyloid40.
Calculators
Common stock solution preparation
Table 1. Volume of DMSO needed to reconstitute specific mass of Half chrysamine G to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.
| 0.1 mg | 0.5 mg | 1 mg | 5 mg | 10 mg | |
| 1 mM | 412.882 µL | 2.064 mL | 4.129 mL | 20.644 mL | 41.288 mL |
| 5 mM | 82.576 µL | 412.882 µL | 825.764 µL | 4.129 mL | 8.258 mL |
| 10 mM | 41.288 µL | 206.441 µL | 412.882 µL | 2.064 mL | 4.129 mL |
Molarity calculator
Enter any two values (mass, volume, concentration) to calculate the third.
| Mass (Calculate) | Molecular weight | Volume (Calculate) | Concentration (Calculate) | Moles | ||||
| / | = | x | = |
References
View all 7 references: Citation Explorer
Mechanism of A beta(1-40) fibril-induced fluorescence of (trans,trans)-1-bromo-2,5-bis(4-hydroxystyryl)benzene (K114)
Authors: LeVine H, 3rd.
Journal: Biochemistry (2005): 15937
Authors: LeVine H, 3rd.
Journal: Biochemistry (2005): 15937
Multiple ligand binding sites on A beta(1-40) fibrils
Authors: LeVine H, 3rd.
Journal: Amyloid (2005): 5
Authors: LeVine H, 3rd.
Journal: Amyloid (2005): 5
Efficient radiosynthesis of carbon-11 labelled uncharged Thioflavin T derivatives using [11C]methyl triflate for beta-amyloid imaging in Alzheimer's Disease with PET
Authors: Solbach C, Uebele M, Reischl G, Machulla HJ.
Journal: Appl Radiat Isot (2005): 591
Authors: Solbach C, Uebele M, Reischl G, Machulla HJ.
Journal: Appl Radiat Isot (2005): 591
Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies
Authors: Ishikawa K, Doh-ura K, Kudo Y, Nishida N, Murakami-Kubo I, Ando Y, Sawada T, Iwaki T.
Journal: J Gen Virol (2004): 1785
Authors: Ishikawa K, Doh-ura K, Kudo Y, Nishida N, Murakami-Kubo I, Ando Y, Sawada T, Iwaki T.
Journal: J Gen Virol (2004): 1785
Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease
Authors: Wang Y, Klunk WE, Debnath ML, Huang GF, Holt DP, Shao L, Mathis CA.
Journal: J Mol Neurosci (2004): 55
Authors: Wang Y, Klunk WE, Debnath ML, Huang GF, Holt DP, Shao L, Mathis CA.
Journal: J Mol Neurosci (2004): 55
Page updated on December 17, 2024
Safety data sheet